ConductScience.org, home

Gene · 353

NIH grants1,685

NIH grants whose papers are about the gene, through NIH's grant-paper links.

81 to 100 of 1,685

Download this page as JSON
GrantTitleAPRT papersNewest fiscal year
P01CA163222Targetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironment12025
P01CA206978Comprehensive dissection of the CLL genome & phenome to improve patient outcomes12025
P01CA217959Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance12025
P20GM103427Nebraska Research Network in Functional Genomics12025
P20GM103449Vermont Biomedical Research Network-Vermont INBRE12025
P20GM109036Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases12025
P20GM121316Nebraska Center for Molecular Target Discovery and Development12025
P20GM125503Center for Musculoskeletal Disease Research (CMDR)12025
P30AG028740University of Florida Older Americans Independence Center (OAIC)12025
P30AG059299San Diego Alzheimer's Disease Resource Center for Minority Aging Research (San Diego AD-RCMAR)12025
P30AG066507Johns Hopkins Alzheimer's Disease Research Center12025
P30AG066511Goizueta Alzheimer's Disease Research Center12025
P30AG072975Rush Alzheimer's Disease Research Center12025
P30AI036214San Diego Center for AIDS Research (SD CFAR)12025
P30AR074990UW Center for Translational Muscle Research12025
P30AR075043University of Michigan Skin Biology and Diseases Resource-based Center12025
P30CA006927Comprehensive Cancer Center Program at Fox Chase12025
P30CA006973Regional Oncology Research Center12025
P30CA010815Consolidated Basic Cancer Research Program12025
P30CA013696Cancer Center Support Grant12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/353/grants?page=5